Macrophage death and defective inflammation resolution in atherosclerosis - PubMed (original) (raw)
Review
Macrophage death and defective inflammation resolution in atherosclerosis
Ira Tabas. Nat Rev Immunol. 2010 Jan.
Abstract
A key event in atherosclerosis is a maladaptive inflammatory response to subendothelial lipoproteins. A crucial aspect of this response is a failure to resolve inflammation, which normally involves the suppression of inflammatory cell influx, effective clearance of apoptotic cells and promotion of inflammatory cell egress. Defects in these processes promote the progression of atherosclerotic lesions into dangerous plaques, which can trigger atherothrombotic vascular disease, the leading cause of death in industrialized societies. In this Review I provide an overview of these concepts, with a focus on macrophage death and defective apoptotic cell clearance, and discuss new therapeutic strategies designed to boost inflammation resolution in atherosclerosis.
Figures
Figure 1. Schematic of a dangerous, or “vulnerable,” atherosclerotic plaque showing the hallmarks of defective resolution of inflammation
Inflammatory cells, including lipid-laden macrophage (Mφ) foam cells, have accumulated in the intima, resulting from both persistent influx of new cells, particularly monocytes, and defective egress of the resident cells. Moreover, dead macrophages are not efficiently cleared by the process of efferocytosis, and so they undergo post- apoptotic necrosis. This process contributes to the formation of the necrotic core, which contributes to plaque disruption, particularly thinning of the fibrous cap. If the process continues, there will be a breach in the fibrous cap, leading to lumenal thrombosis and arterial occlusion.
Figure 2. Efferocytosis and inflammation resolution in early and advanced atherosclerosis
A In early atherosclerotic lesions, efferocytosis is efficient, leading to rapid clearing of apoptotic macrophages (Mφs). This process prevents post-apoptotic cellular necrosis, elicits the production of anti-inflammatory cytokines, and clears macrophages from the lesions. The result of this inflammation resolution process is decreased plaque progression. B In advanced lesions, efferocytes do not function properly and this apoptotic macrophages become secondarily necrotic. The necrotic material is a stimulus for inflammation, and the normal anti-inflammatory signaling associated with efferocytosis does not occur. Moreover, an important mean for ridding the lesion of inflammatory macrophages is lost. Thus, inflammation resolution fails to occur normally, and necrotic macrophages coalesce into necrotic cores. These features define plaques that are vulnerable to rupture. which in turn can trigger acute lumenal thrombosis and arterial occlusion.
Similar articles
- Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency.
Tabas I. Tabas I. Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2255-64. doi: 10.1161/01.ATV.0000184783.04864.9f. Epub 2005 Sep 1. Arterioscler Thromb Vasc Biol. 2005. PMID: 16141399 Review. - 2016 Russell Ross Memorial Lecture in Vascular Biology: Molecular-Cellular Mechanisms in the Progression of Atherosclerosis.
Tabas I. Tabas I. Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):183-189. doi: 10.1161/ATVBAHA.116.308036. Epub 2016 Dec 15. Arterioscler Thromb Vasc Biol. 2017. PMID: 27979856 Free PMC article. Review. - Atherosclerosis - A matter of unresolved inflammation.
Viola J, Soehnlein O. Viola J, et al. Semin Immunol. 2015 May;27(3):184-93. doi: 10.1016/j.smim.2015.03.013. Epub 2015 Apr 10. Semin Immunol. 2015. PMID: 25865626 Review. - Dead cell and debris clearance in the atherosclerotic plaque: Mechanisms and therapeutic opportunities to promote inflammation resolution.
Dhawan UK, Singhal A, Subramanian M. Dhawan UK, et al. Pharmacol Res. 2021 Aug;170:105699. doi: 10.1016/j.phrs.2021.105699. Epub 2021 Jun 2. Pharmacol Res. 2021. PMID: 34087352 Review. - Apoptotic cell clearance: basic biology and therapeutic potential.
Poon IK, Lucas CD, Rossi AG, Ravichandran KS. Poon IK, et al. Nat Rev Immunol. 2014 Mar;14(3):166-80. doi: 10.1038/nri3607. Epub 2014 Jan 31. Nat Rev Immunol. 2014. PMID: 24481336 Free PMC article. Review.
Cited by
- Identification of Key Efferocytosis-Related Genes and Mechanisms in Diabetic Retinopathy.
Qian Y, Jia Y. Qian Y, et al. Mol Biotechnol. 2024 Jul 31. doi: 10.1007/s12033-024-01239-x. Online ahead of print. Mol Biotechnol. 2024. PMID: 39085562 - Recent progress of endoplasmic reticulum stress in the mechanism of atherosclerosis.
Ni L, Yang L, Lin Y. Ni L, et al. Front Cardiovasc Med. 2024 Jul 12;11:1413441. doi: 10.3389/fcvm.2024.1413441. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39070554 Free PMC article. Review. - Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment.
He Z, Chen W, Hu K, Luo Y, Zeng W, He X, Li T, Ouyang J, Li Y, Xie L, Zhang Y, Xu Q, Yang S, Guo M, Zou W, Li Y, Huang L, Chen L, Zhang X, Saiding Q, Wang R, Zhang MR, Kong N, Xie T, Song X, Tao W. He Z, et al. Nat Nanotechnol. 2024 Sep;19(9):1386-1398. doi: 10.1038/s41565-024-01687-1. Epub 2024 Jun 19. Nat Nanotechnol. 2024. PMID: 38898135 - Therapeutic Activity of Resolvin D1 (RvD1) in Murine MASH.
Navarro-Corcuera A, Zhu Y, Ma F, Gupta N, Asplund H, Yuan F, Friedman S, Sansbury BE, Huang X, Cai B. Navarro-Corcuera A, et al. bioRxiv [Preprint]. 2024 Apr 26:2024.04.22.590633. doi: 10.1101/2024.04.22.590633. bioRxiv. 2024. PMID: 38712196 Free PMC article. Preprint. - Trem2 Agonist Reprograms Foamy Macrophages to Promote Atherosclerotic Plaque Stability-Brief Report.
Patterson MT, Xu Y, Hillman H, Osinski V, Schrank PR, Kennedy AE, Barrow F, Zhu A, Tollison S, Shekhar S, Stromnes IM, Tassi I, Wu D, Revelo XS, Binstadt BA, Williams JW. Patterson MT, et al. Arterioscler Thromb Vasc Biol. 2024 Jul;44(7):1646-1657. doi: 10.1161/ATVBAHA.124.320797. Epub 2024 May 2. Arterioscler Thromb Vasc Biol. 2024. PMID: 38695172 Free PMC article.
References
- Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol. 2009;27:451–483. - PubMed
- Braunwald E. Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 1997;337:1360–1369. - PubMed
- NHLBI Morbidity and Mortality Chart Book. (2004).
Publication types
MeSH terms
Grants and funding
- HL75662/HL/NHLBI NIH HHS/United States
- P01 HL054591/HL/NHLBI NIH HHS/United States
- R01 HL075662/HL/NHLBI NIH HHS/United States
- HL54591/HL/NHLBI NIH HHS/United States
- P01 HL054591-140004/HL/NHLBI NIH HHS/United States
- R01 HL075662-07/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical